Search for: "Bristol Myers Squibb"
Results 481 - 500
of 863
Sorted by Relevance
|
Sort by Date
16 Apr 2014, 12:18 pm
See Bristol-Myers Squibb Co. v. [read post]
25 Apr 2007, 5:43 pm
Following Bristol-Myers Squibb Co. v. [read post]
4 Sep 2012, 1:45 pm
Experts further expected that the new drug will generate more sales to its manufacturer since its competing experimental drug from Bristol-Myers Squibb. [read post]
1 Jul 2010, 1:32 pm
Grassley letters are available in the continuation of this blog entryBelow are links to the letters sent by Grassley to: Abbott Laboratories Amgen AstraZeneca Pharmaceuticals Boehringer Bristol-Myers Squibb Company Eisai Corporation of America Eli Lilly and Company Forest Laboratories GlaxoSmithKline Hoffman-La Roche Inc. [read post]
17 Apr 2009, 11:05 am
Such arrangements aren’t unprecedented, though: In 2007, AstraZeneca PLC and Bristol-Myers Squibb Co. struck a partnership to develop and market two diabetes drugs. [read post]
6 Jun 2008, 5:16 pm
Justice Alito also pared some of his stock holdings, according to the report, by selling a stake in Intel and selling part of his holdings in Bristol-Myers Squibb, McDonald and Exxon. [read post]
21 Apr 2023, 9:27 am
Apr. 19, 2023) In 2019, Amgen acquired worldwide rights to apremilast (OTEZLA) from Celgene $13.4 billion in cash, in connection with Celgene’s merger with Bristol-Myers Squibb. [read post]
20 Sep 2017, 9:18 am
In Bristol-Myers Squibb Co. v. [read post]
30 Oct 2013, 2:08 pm
In reviewing the current Bristol-Myers Squibb/Sanofi Pharmaceuticals Plavix Prescribing Information (label revised 9/23/13; accessed 10/30/13), however, there is no mention of hemophilia (nor haemophilia) in that document. [read post]
30 Aug 2021, 12:27 pm
The proper jurisdiction for these suits, as the Seyfarth post notes, became open to debate after a US Supreme Court 2017 decision in Bristol Myers Squibb v Superior Court. [read post]
26 May 2007, 11:26 pm
Bristol-Myers Squibb and Sa nofi-Aventis, which co-market the widely used drug, defended the patent from a challenge by Canadian generic drugmaker Apotex, which briefly flooded the market with copycat Plavix tablets last summer. [read post]
21 Oct 2014, 9:03 am
In Bristol-Myers Squibb Company v. [read post]
7 Apr 2010, 4:37 pm
In June 2005, the feds in New Jersey indicted Frederick Schiff, the CFO of Bristol-Myers Squibb, for failing to disclose material facts to investors. [read post]
13 Feb 2015, 12:00 pm
At issue in the case were Bristol-Myers Squibb’s anticoagulant Coumadin and AstraZeneca’s ulcer drugs Prilosec and Nexium. [read post]
30 Jun 2016, 12:12 pm
Non-clinical studies have demonstrated reversal of all approved NOACs including Daiichi Sankyo's SavaysaTM/Lixiana® (edoxaban), Boehringer Ingelheim's Pradaxa® (dabigatran etexilate), Johnson & Johnson and Bayer's Xarelto® (rivaroxaban), and Bristol-Myers Squibb and Pfizer's Eliquis® (apixaban). [read post]
16 Feb 2011, 12:04 am
It looks like they would also do away with all the problems of the “threshold” requirement introduced by Phillips v Mirabella (the nature of the problem is laid out at paragraphs 19 to 27 of Bristol-Myers Squibb v Faulding). [read post]
25 Apr 2010, 5:52 pm
Bristol-Myers Squibb Co. [read post]
19 Oct 2011, 2:30 pm
Bristol-Myers Squibb and Sanofi-Aventis are arguing that centralizing the cases before Judge Freda Wolfson in the U.S. [read post]
15 Apr 2010, 4:27 am
(EPLAW) Prevacid (Lansoprazole) – US: Takeda files patent infringement complaint against Zydus following Para IV challenge (Patent Docs) Reyataz (Atazanavir) – US: Bristol-Myer Squibb, Novartis file patent infringement suit against Teva following Para IV challenge (Patent Docs) Treximet (Sumatriptan, Naproxen) – US: POZEN enters into settlement agreement with Teva regarding Para IV patent litigation (SmartBrief) Zerit (Stavudine) – US: Promote… [read post]
28 Aug 2018, 12:16 am
Although fact-specific, this case sets a threshold as to actions which would not constitute the repackaging of products (whilst Bristol-Myers Squibb and Boehringer Ingelheim set out actions which would). [read post]
